TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BGM

Qilian International Holding Group Limited

Healthcare · Drug Manufacturers - Specialty & Generic

0.244$ +1.7% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Qilian International Holding Group Limited (BGM)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 35.0% of the shares are freely tradable; institutional investors hold 0.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 0.04%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 44.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 35.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 381Mio.

Largest Shareholders

Institutions

Institutions BGM
Name Stake (%) Shares Change (%) Date
HRT FINANCIAL LLC 0.24 48,174 +0.0 03/31/2026
Geode Capital Management, LLC 0.23 46,961 -0.4 03/31/2026
State Street Corp 0.23 46,532 -5.3 03/31/2026
TWO SIGMA SECURITIES, LLC 0.08 16,075 +0.0 03/31/2026
Susquehanna International Group, LLP 0.08 15,737 +0.0 03/31/2026
XTX Topco Ltd 0.06 11,437 +0.0 03/31/2026
Ground Swell Capital, LLC 0.06 11,101 +0.0 06/30/2026
Tower Research Capital LLC 0.04 8,214 +1,629.3 03/31/2026

Funds

Funds BGM
Name Stake (%) Shares Change (%) Date
Fidelity Nasdaq Composite ETF 0.03 62,099 +0.0 08/31/2026
Fidelity Nasdaq Composite Index 0.02 36,313 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?